Global Intravitreal Injectable Market Report, History and Forecast 2016-2027, Breakdown Data by Manufacturer
- April 2021
- 112 pages
In 2020, the global Intravitreal Injectable market size was US$ 13.72 billion and it is expected to reach US$ 21.96 billion by the end of 2027, with a CAGR of 7.13% between 2021 and 2027.
Global Intravitreal Injectable Scope and Market Size
The global Intravitreal Injectable market is segmented by region (country), company, by Drug, and by Disease. Players, stakeholders, and other participants in the global Intravitreal Injectable market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Drug, and by Disease for the period 2016-2027.
Regeneron Pharmaceuticals (Eylea)
Segment by Drug
Segment by Disease
Retinal Vein Occlusion
Middle East & Africa
Have query on this report?Make an Enquiry
1.1 Intravitreal Injectable Product Overview1
1.2 Intravitreal Injectable Market Segment by Drug3
Table 2. Global Intravitreal Injectable Sales by Drug (2016-2021) & (K Units)8
Table 3. Global Intravitreal Injectable Sales Market Share in Volume by Drug (2016-2021)8
Table 4. Global Intravitreal Injectable Sales by Drug (2016-2021) & (US$ Million)9
Table 5. Global Intravitreal Injectable Sales Market Share in Value by Drug (2016-2021)9
Table 6. Global Intravitreal Injectable Price by Drug (2016-2021) & (USD/Unit)10
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017